Angle PLC Announces Potential in Immunotherapy Treatment Selection
PEER-REVIEWED PUBLICATION HIGHLIGHTS POTENTIAL FOR PARSORTIX SYSTEM IN IMMUNOTHERAPY TREATMENT SELECTIONParsortix isolation of CTCs highlights relationship between PD-L1 expression and...